Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thatcher

Showing results (231-240 of 289) with videos related to

Pageof 29
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
Urinary-derived monocyte-colony stimulating factor (P-100) following treatment with carboplatin and etoposide in small cell lung cancer (SCLC)M E Van Hoef, J A Radford, A Jones, et al.
European Journal of Clinical Investigation|September 8, 2015
Response to 'How we define hyponatremia?'P Grant, J Ayuk, P-M Bouloux, et al.
Cancer Treatment Reports|September 1, 1987
Phase I clinical trial of methylene dimethane sulfonateD B Smith, B W Fox, N Thatcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 17, 2005
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancerS Baka, L Ashcroft, H Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Neurological and cognitive impairment in long-term survivors of small cell lung cancerA Cull, A Gregor, P Hopwood, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factorH Gurney, H Anderson, J Radford, et al.
British Journal of Cancer|January 1, 1997
Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancerP J Woll, R Basser, T Le Chevalier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2017
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trialE Lesaffre, M J Edelman, N H Hanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanomaS Danson, P Lorigan, A Arance, et al.
Organic Letters|June 17, 2005
Position of coordination of the lithium ion determines the regioselectivity of demethylations of 3,4-dimethoxymorphinans with L-selectrideHuifang Wu, Linn N Thatcher, Denzil Bernard, et al.
Pageof 29

Showing results (231-240 of 289) with videos related to

Sort By:
Pageof 29
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
Urinary-derived monocyte-colony stimulating factor (P-100) following treatment with carboplatin and etoposide in small cell lung cancer (SCLC)M E Van Hoef, J A Radford, A Jones, et al.
European Journal of Clinical Investigation|September 8, 2015
Response to 'How we define hyponatremia?'P Grant, J Ayuk, P-M Bouloux, et al.
Cancer Treatment Reports|September 1, 1987
Phase I clinical trial of methylene dimethane sulfonateD B Smith, B W Fox, N Thatcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 17, 2005
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status </= 70) and advanced non-small-cell lung cancerS Baka, L Ashcroft, H Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Neurological and cognitive impairment in long-term survivors of small cell lung cancerA Cull, A Gregor, P Hopwood, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factorH Gurney, H Anderson, J Radford, et al.
British Journal of Cancer|January 1, 1997
Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancerP J Woll, R Basser, T Le Chevalier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2017
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trialE Lesaffre, M J Edelman, N H Hanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanomaS Danson, P Lorigan, A Arance, et al.
Organic Letters|June 17, 2005
Position of coordination of the lithium ion determines the regioselectivity of demethylations of 3,4-dimethoxymorphinans with L-selectrideHuifang Wu, Linn N Thatcher, Denzil Bernard, et al.
Pageof 29